Middle East & Africa Veterinary Healthcare Market Report

Middle East and Africa Veterinary Healthcare Market Size

The Middle East and Africa veterinary healthcare market size was valued at USD 4.08 billion in 2025 and is anticipated to reach USD 4.36 billion in 2026 from USD 7.39 billion by 2034, growing at a CAGR of 6.8% during the forecast period from 2026 to 2034.

Veterinary Healthcare refers to medical services, pharmaceuticals, diagnostics, and preventive care designed to ensure the health and productivity of livestock, companion animals, and equines across the region. This sector plays a pivotal role in supporting food security, rural livelihoods, and zoonotic disease control, particularly in agrarian economies where animal husbandry is deeply interwoven with economic stability.

As of 2023, livestock accounts for approximately 30% of agricultural GDP in sub-Saharan Africa, according to the Food and Agriculture Organization of the United Nations, underlining the economic significance of animal health. In the Middle East, rising pet ownership in countries like the UAE and Saudi Arabia has catalyzed demand for advanced veterinary services, including specialty care and wellness programs. As per the World Organisation for Animal Health, over 70% of emerging infectious diseases in humans originate from animals, reinforcing the necessity of robust veterinary surveillance systems across the region. Additionally, as per the International Livestock Research Institute, more than 200 million smallholder farmers in Africa depend on livestock for income, milk, and draft power, making veterinary healthcare a critical enabler of rural resilience. The expansion of veterinary infrastructure is further supported by increasing regulatory attention to animal welfare and food safety standards, particularly in Gulf Cooperation Council (GCC) nations that import live animals and animal products at scale.

MARKET DRIVERS

Rising Livestock Production and Food Security Imperatives

The expansion of livestock production across the Middle East and Africa is a foundational driver of veterinary healthcare demand, rooted in the region’s growing population and increasing reliance on animal-sourced proteins. This growth is propelled by urbanization and rising incomes, particularly in Nigeria, Ethiopia, and Kenya, where demand for milk, eggs, and red meat has surged. In Sudan and Somalia, livestock contributes notably to agricultural output, necessitating disease prevention and herd health management. The prevalence of transboundary animal diseases, such as foot-and-mouth disease, peste des petits ruminants (PPR), and Rift Valley fever, further amplifies the need for vaccines, diagnostics, and veterinary interventions. National governments and regional bodies like the Intergovernmental Authority on Development (IGAD) have launched mass vaccination campaigns, with a substantial number of small ruminants vaccinated against PPR between 2019 and 2023. This alignment of food security goals, economic dependency on livestock, and disease control initiatives establishes livestock productivity as a central pillar driving veterinary healthcare investment.

Increasing Pet Ownership and Urbanization in the Middle East

Urbanization and shifting social dynamics in the Gulf region have led to a significant rise in pet ownership, transforming companion animal care into a growing segment of veterinary healthcare. In countries such as the United Arab Emirates and Saudi Arabia, pet ownership has become increasingly common among expatriate communities and affluent nationals, with dogs and cats now seen as family members rather than mere animals. THe cultural shift has spurred demand for premium veterinary services, including dental care, orthopedic surgery, and chronic disease management. Additionally, mandatory pet microchipping and vaccination laws in the UAE have institutionalized routine veterinary engagement. The rise of pet insurance, specialty clinics, and 24-hour emergency hospitals further reflects the maturation of the companion animal healthcare ecosystem. As urban centers expand and middle-class households adopt pets, the demand for professional veterinary care is expected to grow in tandem, particularly in newly developed residential zones where pet-friendly policies are increasingly enforced.

MARKET RESTRAINTS

Limited Veterinary Infrastructure and Workforce Shortages

The severe shortage of trained professionals and inadequate clinical infrastructure, particularly in rural and remote regions is a critical impediment to the advancement of veterinary healthcare in the Middle East and Africa. According to the World Organisation for Animal Health, Africa has an average of only one veterinarian per 100,000 livestock, a ratio far below the recommended standard for effective disease surveillance and response. In Ethiopia, which houses one of the largest livestock populations on the continent, there are fewer than 4,000 practicing veterinarians, as reported by the Ministry of Agriculture, leaving vast pastoral areas underserved. Similarly, in West African nations such as Niger and Chad, veterinary clinics are often concentrated in capital cities, leaving rural farmers without access to basic services like vaccination or parasite control. The International Livestock Research Institute estimates that a portion of livestock deaths in sub-Saharan Africa occur due to preventable diseases that could be mitigated with timely veterinary intervention. Mobility and supply chain constraints further limit field operations. Additionally, training institutions are insufficient in number and capacity. This human resource deficit hampers both public health initiatives and private sector growth, constraining the scalability of veterinary healthcare services across the region.

Economic Volatility and Limited Government Funding for Animal Health Programs

Sustained investment in veterinary healthcare is frequently undermined by economic instability and inconsistent public funding, particularly in low- and middle-income countries across the region. In Zimbabwe, for example, recurrent currency crises have disrupted the importation of vaccines and essential medicines, leading to outbreaks of preventable diseases such as lumpy skin disease in cattle, as documented by the Department of Veterinary Services. Similarly, in Sudan, prolonged conflict has dismantled veterinary supply chains, with over 70% of animal health facilities in conflict-affected regions non-operational. Even in more stable economies, veterinary budgets remain disproportionately low. Gulf nations, while wealthier, often prioritize human healthcare and infrastructure, leaving veterinary services underfunded relative to demand. Additionally, donor-dependent programs face sustainability challenges. Without stable financial mechanisms, vaccination campaigns, diagnostic labs, and disease surveillance systems remain fragmented, weakening the overall resilience of the veterinary healthcare ecosystem.

MARKET OPPORTUNITIES

Expansion of Vaccination Programs and Regional Disease Eradication Initiatives

A transformative opportunity lies in the ongoing regional efforts to eradicate endemic animal diseases through coordinated vaccination campaigns, which are creating sustained demand for veterinary biologics and field services. The initiative has mobilized international funding from organizations such as the Food and Agriculture Organization and the World Bank, enabling the establishment of cold chains, training of field veterinarians, and cross-border coordination. In the Middle East, the Gulf Cooperation Council has implemented harmonized vaccination protocols for diseases like Rift Valley fever and avian influenza, particularly in high-risk areas such as Yemen and Oman. The success of these programs has encouraged private sector participation, with pharmaceutical companies like Boehringer Ingelheim and Ceva Santé Animale expanding their vaccine distribution networks in Africa. Mobile vaccination units and drone-based delivery systems are being piloted in Kenya and Rwanda, improving last-mile access. As governments recognize the economic benefits of disease-free status—such as improved export eligibility and reduced livestock mortality—the institutionalization of preventive veterinary care is gaining momentum, opening avenues for long-term market development.

Growth of Veterinary Diagnostics and Digital Health Monitoring

The integration of diagnostics and digital health technologies presents a significant growth frontier for veterinary healthcare in the Middle East and Africa, driven by the need for early disease detection and improved herd management. Traditional reliance on clinical observation is being supplemented by rapid diagnostic tests, mobile labs, and tele-veterinary platforms that enhance accuracy and response speed. In the UAE, smart collars and RFID tags are increasingly used in camel and dairy farms to monitor vital signs, fertility cycles, and feeding patterns, enabling data-driven decision-making. Additionally, telemedicine platforms like VetAfrica and VetNow are connecting remote farmers with veterinary experts via mobile apps, overcoming geographic barriers. With donor agencies and development banks investing in veterinary innovation hubs, the convergence of biotechnology, connectivity, and data analytics is poised to revolutionize animal healthcare delivery across the region.

MARKET CHALLENGES

Cross-Border Animal Movement and Disease Transmission Risks

The unregulated movement of livestock across national borders in the Middle East and Africa poses a persistent challenge to veterinary healthcare, facilitating the rapid spread of contagious diseases and undermining containment efforts. The informal trade, while economically vital, increases the risk of introducing pathogens such as foot-and-mouth disease, contagious bovine pleuropneumonia, and lumpy skin disease into disease-free zones. Border checkpoints often lack trained personnel, diagnostic tools, or refrigerated storage for vaccines, limiting enforcement capacity. Additionally, cultural practices such as seasonal pastoral migration further complicate control measures. The absence of harmonized regional health certifications and traceability systems exacerbates the problem, preventing timely intervention. While initiatives like the African Continental Free Trade Area emphasize safe trade, implementation remains inconsistent, leaving veterinary authorities in a reactive rather than preventive posture.

Climate Change and Environmental Stressors on Animal Health

Climate variability is emerging as a critical challenge to veterinary healthcare in the Middle East and Africa, exacerbating disease prevalence, reducing feed availability, and increasing animal mortality. Rising temperatures also expand the geographic range of disease vectors. Similarly, increased humidity in West Africa has accelerated the spread of trypanosomiasis, transmitted by tsetse flies. Heat stress is another growing concern. These environmental pressures demand adaptive veterinary strategies, including heat-tolerant breeds, vector control programs, and climate-resilient feed systems. However, limited research funding and fragmented policy responses hinder large-scale implementation, leaving animal health systems vulnerable to escalating climatic disruptions.

REPORT COVERAGE

SEGMENTAL ANALYSIS

By Animal Type Insights

The livestock animals segment constituted the largest part of the Middle East & Africa Veterinary Healthcare Market by capturing a 68.1% share in 2025. This dominance is intrinsically linked to the region’s economic reliance on animal agriculture, particularly in sub-Saharan Africa and the arid pastoral zones of the Horn and Sahel. The economic weight of livestock is further underscored by its contribution to GDP. This scale necessitates widespread veterinary interventions, particularly vaccinations, deworming, and treatment of endemic diseases such as contagious bovine pleuropneumonia and trypanosomiasis. A critical factor reinforcing the segment’s dominance is the persistent threat of transboundary animal diseases that jeopardize both domestic productivity and international trade. The integration of livestock into rural credit systems, where animals serve as collateral, further incentivizes health investment.

The companion animals segment is experiencing the most rapid growth in the Middle East & Africa Veterinary Healthcare Market and is projected to expand at a CAGR of 10.3% from 2025 to 2033. This acceleration is primarily driven by shifting socio-cultural attitudes toward pet ownership, particularly in the urban centers of the Gulf Cooperation Council (GCC) nations. The emotional attachment translates into higher spending on veterinary services, including preventive care, dental treatments, and chronic disease management. Additionally, the expatriate population plays a pivotal role in shaping pet care norms, bringing with them Western-style expectations for animal welfare and medical standards. A further key driver is the implementation of regulatory frameworks that institutionalize veterinary engagement. In Saudi Arabia, the introduction of pet-friendly housing policies and the approval of pet stores in major malls signal a broader societal shift. The Kingdom’s Vision 2030 includes provisions for animal welfare reform, with plans to establish specialized veterinary hospitals in Riyadh and Jeddah. Private investment is following suit. The rise of pet insurance, specialty clinics, and 24-hour emergency services further indicates market maturation. With pet ownership still in its early adoption phase across most of the region, the companion animal segment is poised for sustained expansion, particularly as younger, urban populations embrace pets as symbols of modern lifestyle and emotional well-being.

By Product Insights

The Pharmaceuticals segment represent the largest product in the Middle East & Africa Veterinary Healthcare Market by accounting for a 62.6% of total revenue in 2025. This dominance is due to the high prevalence of infectious and parasitic diseases that require continuous medical intervention across both livestock and companion animal populations. Similarly, bacterial infections like brucellosis and mastitis significantly impact dairy productivity, necessitating widespread antibiotic use. Vaccines also form a core component of the pharmaceutical segment. These large-scale public health initiatives, often funded by international donors, create sustained demand for injectables, oral medications, and biologics. An additional major factor reinforcing pharmaceutical dominance is the limited availability of alternative treatment modalities in rural areas. Diagnostic tools and surgical facilities remain scarce, particularly in remote pastoral regions, making drug-based interventions the primary recourse for disease management. The informal distribution of veterinary drugs through agro-veterinary shops further amplifies market penetration, despite concerns about quality control. In the Middle East, the rise of intensive livestock farming—such as poultry operations in Egypt and dairy farms in Saudi Arabia—has increased prophylactic use of antibiotics and antiparasitics to prevent disease outbreaks in high-density environments. While global pressure to reduce antimicrobial resistance is growing, the absence of viable alternatives ensures that pharmaceuticals will remain the cornerstone of veterinary healthcare across the region for the foreseeable future.

The feed additives segment is emerging as the fastest-growing category in the Middle East & Africa Veterinary Healthcare Market, with a projected CAGR of 9.7% from 2025 to 2033. This growth is fueled by the expansion of commercial livestock farming and the increasing need to enhance animal productivity in resource-constrained environments. Similarly, in Saudi Arabia, where nearly all animal feed is imported or artificially produced, feed additives are critical for maintaining livestock health in extreme climatic conditions. A key driver of this segment’s acceleration is the rising incidence of feed contamination due to poor storage and climatic factors. In addition, mycotoxin binders have become essential in feed formulations, particularly in maize-dependent regions like Kenya and Nigeria. Additionally, the push for antibiotic-free production has boosted demand for probiotics, prebiotics, and phytogenics as natural growth promoters. Regulatory support is also growing; the Gulf Standardization Organization has established maximum residue limits for contaminants, encouraging safer feed practices. With intensification of animal farming and climate-related feed challenges expected to persist, the role of additives in ensuring animal health and productivity will continue to expand.

REGIONAL ANALYSIS

Saudi Arabia (KSA) Veterinary Healthcare Market Insights

Saudi Arabia led the Middle East & Africa Veterinary Healthcare Market by accounting for a 22.5% of regional value in 2025. The Kingdom’s lead position is anchored in its high public and private investment in animal health, driven by food security imperatives and social transformation under Vision 2030. The government mandates vaccination programs for diseases such as avian influenza and foot-and-mouth disease, ensuring consistent demand for vaccines and pharmaceuticals. Simultaneously, the rapid rise in pet ownership—particularly among women and youth—has spurred the development of specialty clinics and diagnostic centers in Riyadh, Jeddah, and the NEOM megacity. The country’s advanced cold chain infrastructure and import capacity enable a reliable supply of biologics and therapeutics. Additionally, public-private partnerships are fostering innovation, such as the collaboration between King Saud University and Boehringer Ingelheim on camel respiratory disease research. With sustained government backing and evolving consumer behavior, Saudi Arabia remains the most dynamic and strategically significant veterinary market in the region.

Saudi Arabia (KSA) Veterinary Healthcare Market Insights

South Africa occupied a significant position in the Middle East & Africa Veterinary Healthcare. The country’s prominence is rooted in its relatively advanced veterinary infrastructure, regulatory framework, and integration into global agricultural trade networks. As a major exporter of beef, wool, and live animals to the Middle East and Europe, South Africa must comply with stringent animal health certifications, necessitating robust disease surveillance and control systems. The country hosts the region’s most developed veterinary education system, with five accredited veterinary schools producing skilled professionals who support both public and private sectors. In the companion animal space, urban centers like Johannesburg and Cape Town have seen a surge in pet insurance uptake and specialty care. The presence of multinational pharmaceutical companies and regional distribution hubs further strengthens market depth. Despite challenges such as farm insecurity and drought, South Africa remains a benchmark for veterinary governance and service delivery in Africa.

United Arab Emirates (UAE) Veterinary Healthcare Market Insights

The United Arab Emirates ranks as the third-largest veterinary healthcare market in the region, holding an estimated 14% share in 2025, according to the Gulf Standardization Organization. Its position is defined by high per capita spending on animal health, driven by a combination of affluent pet ownership, elite equine industries, and strategic livestock imports. The UAE enforces strict quarantine and vaccination protocols for imported animals, ensuring continuous demand for diagnostics and pharmaceuticals. The country also hosts the region’s largest equine population, necessitating specialized orthopedic and surgical care. Additionally, the UAE serves as a regional distribution hub for veterinary products, with Jebel Ali Free Zone hosting major logistics operations for companies like Zoetis and Ceva. With strong regulatory enforcement and high disposable income, the UAE sets the standard for premium veterinary service delivery in the Middle East.

COMPETITIVE LANDSCAPE

The competitive landscape of the Middle East & Africa Veterinary Healthcare Market is characterized by a convergence of global pharmaceutical leaders, regional distributors, and emerging local manufacturers, each navigating a complex terrain of economic disparity, regulatory variance, and diverse animal husbandry systems. Multinational corporations such as Zoetis, Merck, and Boehringer Ingelheim dominate through brand recognition, scientific innovation, and established supply chains, yet face increasing pressure from cost-effective regional players who offer adapted formulations at lower price points. In countries like Egypt and South Africa, domestic manufacturers are gaining ground by producing generic vaccines and antibiotics that meet national standards while remaining affordable for smallholder farmers. The market is further fragmented by informal distribution networks, where unregulated products often reach remote areas faster than formal channels. In the Gulf, competition centers on premiumization, with companies differentiating through advanced diagnostics, specialty care, and digital integration. Conversely, in sub-Saharan Africa, the race is defined by accessibility, durability, and ease of administration in off-grid environments. The rise of mobile veterinary services, telemedicine, and drone-based delivery is reshaping service models, enabling both global and local firms to expand reach. Ultimately, success in this market hinges not on scale alone, but on the ability to balance scientific excellence with cultural sensitivity, logistical resilience, and adaptive business models that respond to the region’s vast heterogeneity.

KEY MARKET PLAYERS

A few of the noteworthy companies in the MEA veterinary healthcare market include

• Merck & Co., Inc.
• Bayer AG
• Boehringer Ingelheim GmbH
• Cargill, Inc.
• Ceva Santé Animale
• Novasep
• Eli Lilly and Company
• Koninklijke DSM N.V.
• Novartis AG
• Nutreco N.V.
• Sanofi S.A.
• SeQuent Scientific Ltd.
• Virbac S.A.
• Vétoquinol S.A.
• Zoetis Inc.

Top Players in the Market

Zoetis stands as a dominant force in the Middle East & Africa Veterinary Healthcare Market, leveraging its global leadership in animal health innovation to shape regional standards of care. The company has established a strong presence through strategic partnerships with government agencies, veterinary associations, and distribution networks across key markets such as South Africa, Saudi Arabia, and Kenya. Known for its broad portfolio of vaccines, anti-infectives, and specialty medicines, Zoetis emphasizes science-driven solutions tailored to both livestock productivity and companion animal wellness. Its commitment to research and development enables the adaptation of global products to regional disease challenges, including Rift Valley fever and peste des petits ruminants. By investing in technical training for veterinarians and supporting disease surveillance initiatives, Zoetis strengthens its reputation as a trusted partner in public and private animal health ecosystems. Its integration of digital tools and data analytics further enhances client engagement, positioning the company as a forward-thinking leader in advancing veterinary care across diverse economic and climatic landscapes.

Merck Animal Health (MSD Animal Health) plays a pivotal role in shaping veterinary healthcare delivery across the Middle East and Africa through its extensive vaccine portfolio and long-standing engagement in disease control programs. The company has been instrumental in supporting regional eradication efforts for transboundary animal diseases, particularly through large-scale vaccination campaigns in collaboration with intergovernmental bodies and national ministries. Merck’s focus on livestock health aligns closely with food security priorities, enabling sustainable farming practices in resource-limited settings. It has also expanded its footprint in the companion animal segment by introducing advanced therapeutics and preventive care solutions in urban centers. By fostering scientific collaboration and capacity-building initiatives, including training for field veterinarians and laboratory technicians, Merck strengthens local health infrastructure. Its emphasis on regulatory compliance and product safety has earned widespread trust among public and private stakeholders. The company’s ability to combine global expertise with on-the-ground adaptability allows it to maintain a resilient presence across both commercial and subsistence farming systems, reinforcing its status as a cornerstone player in the region’s evolving veterinary landscape.

Boehringer Ingelheim Animal Health has solidified its influence in the Middle East & Africa by prioritizing innovation, sustainability, and integrated health solutions for livestock and companion animals. The company has developed a reputation for addressing complex disease challenges through biologically advanced vaccines and parasiticides, particularly in cattle, poultry, and swine sectors. Its engagement in public-private partnerships has enabled scalable disease prevention programs, especially in East Africa and the Gulf region. Boehringer Ingelheim emphasizes long-term veterinary capacity development, supporting education initiatives and field research to improve animal health outcomes. In urban markets, the company has strengthened its companion animal offerings, focusing on chronic disease management and preventive care. By aligning with regional agricultural development goals and animal welfare reforms, it positions itself as a strategic enabler of resilient food systems. Its commitment to reducing antimicrobial reliance through alternative health solutions further distinguishes its approach. With a focus on scientific rigor and local collaboration, Boehringer Ingelheim continues to expand its footprint as a transformative force in veterinary healthcare across the region.

Top Strategies Used by Key Market Participants

One of the most impactful strategies employed by leading veterinary healthcare companies in the Middle East and Africa is the development of region-specific product formulations and delivery mechanisms. Recognizing the diversity of climates, animal species, and disease profiles, firms are tailoring vaccines, pharmaceuticals, and diagnostics to address local challenges such as heat-stable vaccine requirements or vector-borne diseases prevalent in tropical zones. This localization enhances efficacy and adoption, particularly in rural and pastoral areas where standard products may fail under extreme conditions.

Another key strategy is the establishment of public-private partnerships to support national and regional disease control initiatives. Companies are collaborating with governments, international organizations, and veterinary associations to co-fund vaccination campaigns, train animal health workers, and strengthen surveillance systems. These alliances not only expand market reach but also build institutional trust and ensure alignment with public health priorities.

A third strategic priority is investment in technical education and field support networks. By training veterinarians, para-veterinarians, and farm advisors, companies enhance product utilization and improve animal health outcomes. Mobile clinics, digital advisory platforms, and on-farm demonstrations are increasingly used to bridge knowledge gaps and foster long-term customer loyalty, particularly in underserved rural communities.

RECENT MARKET DEVELOPMENTS

In March 2023, Zoetis launched a regional training initiative in Nairobi to enhance veterinary capacity in East Africa, focusing on disease diagnostics and vaccine administration for smallholder farmers.
In June 2023, Merck Animal Health partnered with the Saudi Ministry of Environment, Water and Agriculture to support a nationwide camel vaccination program targeting respiratory diseases.
In September 2023, Boehringer Ingelheim inaugurated a technical support hub in Dubai to provide real-time advisory services to livestock producers across the GCC and East Africa.
In January 2024, Ceva Santé Animale introduced a heat-stable poultry vaccine in Nigeria, designed to maintain efficacy without refrigeration in remote farming areas.
In February 2024, Elanco Animal Health expanded its distribution network into Sudan through a strategic alliance with a local agro-veterinary supplier to improve access to parasiticides and antibiotics.

MARKET SEGMENTATION

This research report on the MEA veterinary healthcare market has been segmented and sub-segmented into the following categories.

By Animal Type

• Livestock Animals
• Companion Animals

By Product

• Pharmaceuticals
• Feed Additives

By Country

• KSA
• UAE
• Israel
• rest of GCC countries
• South Africa
• Ethiopia
• Kenya
• Egypt
• Sudan
• Rest of MEA